SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011508
Filing Date
2021-08-12
Accepted
2021-08-12 16:54:14
Documents
57
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cycc-20210630x10q.htm   iXBRL 10-Q 1223375
2 EX-1.1 cycc-20210630xex1d1.htm EX-1.1 360641
3 EX-5.1 cycc-20210630xex5d1.htm EX-5.1 16584
4 EX-31.1 cycc-20210630xex31d1.htm EX-31.1 14688
5 EX-31.2 cycc-20210630xex31d2.htm EX-31.2 15246
6 EX-32.1 cycc-20210630xex32d1.htm EX-32.1 5091
7 EX-32.2 cycc-20210630xex32d2.htm EX-32.2 5435
8 GRAPHIC cycc-20210630xex5d1001.jpg GRAPHIC 6356
  Complete submission text file 0001558370-21-011508.txt   5262563

Data Files

Seq Description Document Type Size
9 EX-101.SCH cycc-20210630.xsd EX-101.SCH 34956
10 EX-101.CAL cycc-20210630_cal.xml EX-101.CAL 34426
11 EX-101.DEF cycc-20210630_def.xml EX-101.DEF 161301
12 EX-101.LAB cycc-20210630_lab.xml EX-101.LAB 316101
13 EX-101.PRE cycc-20210630_pre.xml EX-101.PRE 269790
14 EXTRACTED XBRL INSTANCE DOCUMENT cycc-20210630x10q_htm.xml XML 684387
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 211168392
SIC: 2834 Pharmaceutical Preparations